Latest News in the pharma Industry

Policy & Regulation

Alcon receives FDA approval for pre-loaded intraocular lens delivery system to treat patients undergoing cataract surgery

Alcon receives FDA approval for pre-loaded intraocular lens delivery system to treat patients undergoing cataract surgery

5 Oct 2015

Read more 
UK and India regulators agree deal for closer collaboration to improve public safety

UK and India regulators agree deal for closer collaboration to improve public safety

5 Oct 2015

MHRA signs Memorandum of Understanding with its counterpart body in India.

Read more 
FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept

FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept

2 Oct 2015

Sandoz is seeking approval for all indications included in the reference product's label.

Read more 
FTC files amicus brief explaining that pharmaceutical “product hopping” can violate the antitrust laws

FTC files amicus brief explaining that pharmaceutical “product hopping” can violate the antitrust laws

2 Oct 2015

The FTC filed its amicus brief in a private antitrust action in which Mylan Phamraceuticals Inc. alleges that Warner Chilcott PLC/Mayne Pharma Group maintained a monopoly in the market for its antibiotic Doryx by suppressing generic competition through...

Read more 
Sanofi NDA for lixisenatide accepted for review by FDA

Sanofi NDA for lixisenatide accepted for review by FDA

30 Sep 2015

First New Drug Application for a GLP-1 receptor agonist to include CV outcomes data.

Read more 
Lilly and Sanofi reach settlement agreement in US insulin glargine litigation

Lilly and Sanofi reach settlement agreement in US insulin glargine litigation

28 Sep 2015

Pending final FDA approval, Basaglar can be launched in the US beginning on 15 December 2016.

Read more 
Novo Nordisk receives US FDA approval for Tresiba and Ryzodeg 70/30

Novo Nordisk receives US FDA approval for Tresiba and Ryzodeg 70/30

28 Sep 2015

Read more 
Allergan launches generic version of Invega

Allergan launches generic version of Invega

25 Sep 2015

Allergan is the first company to receive FDA approval for and launch a generic version of Janssen's Invega.

Read more 
Pfizer’s Sayana Press becomes first injectable contraceptive in the UK available for administration by self-injection

Pfizer’s Sayana Press becomes first injectable contraceptive in the UK available for administration by self-injection

24 Sep 2015

Builds on current momentum towards broadening access to this contraceptive option for women across the globe.

Read more 
Munich Re and Marsh launch innovative NDBI cover for US life science companies

Munich Re and Marsh launch innovative NDBI cover for US life science companies

24 Sep 2015

The new non-damage business interruption insurance NDBI Pharma IQ combines risk transfer and consulting services to assist life sciences companies in managing the impact of regulatory actions imposed by the FDA.

Read more 
Taiho Oncology announces FDA approval of Lonsurf for refractory metastatic colorectal cancer

Taiho Oncology announces FDA approval of Lonsurf for refractory metastatic colorectal cancer

23 Sep 2015

Lonsurf represents the first FDA-approved product for Taiho Oncology, setting the stage for the company’s oncology pipeline.

Read more 
Swissmedic approves Novartis' new heart failure medicine Entresto

Swissmedic approves Novartis' new heart failure medicine Entresto

22 Sep 2015

Decision by Swiss Health Authority follows FDA approval of Entresto in July, and serves as an important reference approval for multiple other health authorities.

Read more